Improved health-related quality of life outcomes associated with SHH subgroup medulloblastoma in SIOP-UKCCSG PNET3 trial survivors

Acta Neuropathol. 2014 Jul;128(1):151-3. doi: 10.1007/s00401-014-1300-4. Epub 2014 May 31.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Age Factors
  • Brain Neoplasms / genetics*
  • Brain Neoplasms / therapy*
  • Female
  • Hedgehog Proteins / genetics*
  • Humans
  • Infant
  • Male
  • Medulloblastoma / genetics*
  • Medulloblastoma / therapy*
  • Prognosis
  • Quality of Life*
  • Sex Factors
  • Survival Analysis
  • Treatment Outcome

Substances

  • Hedgehog Proteins
  • SHH protein, human